Strata Critical Medical - Class A Share Price Today
Strata Critical Medical - Class A opened lower at $5.76, compared with its previous close of $6.01. In the last trading session, the stock traded between $5.76 and $5.97. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 2 years ago in Strata Critical Medical - Class A is now worth
$ 131.74
Giving a profit of
$ 31.74 (31.74%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
$-0.25 (-4.21%)
Day High
$5.97
Day Low
$5.76
Day Open
$5.76
Prev Close
$6.01
Volume
8,56,021
1W Return
10.39%
1M Return
26.67%
3M Return
-4.46%
6M Return
1.71%
1Y Return
14.23%
Fundamentals
Market Cap ($ Mn)
514
PE Ratio
-
PB Ratio
1.89
PEG Ratio
-
ROE
-8.18%
ROCE
-9.30%
EPS (TTM)
$-0.09
Investment Returns
1 Week
10.39%
1 Month
26.67%
3 Months
-4.46%
6 Months
1.71%
9 Months
29.37%
Financials
Quarterly
All values in $ Mn
70.8
Jun 25
49.3
Sep 25
66.8
Dec 25
67.4
Mar 26
72.5
Jun 26
74.1
Sep 26
Updates
16Oct
Third Point urges Strata Critical Medical to explore sale, calls stock undervalued
Third Point holds 5.8% stake in Strata Critical Medical. Activist urges exploration of strategic alternatives including sale. Firm states common stock is "undervalued" despite strong business. Management incentive options cited as misaligned with shareholder value.
28 days ago
28Sep
Strata Critical Medical Q2FY26 Results: Revenue rises 60.7% YoY to $72.5 million
Total revenue rose 60.7% YoY to $72.5 million in Q2FY26. Clinical revenue increased 22.6% sequentially to $24.3 million. Adjusted EBITDA reached $7.9 million, with free cash flow at $2.9 million. Full-year 2026 revenue guidance raised to $285–$295 million. Logistics gross margin fell to 18.4% due to fuel surcharges and mix shifts.
1mo ago
4Aug
Strata Critical Medical Q2 Results: Revenue Jumps 60.7% YoY
Strata Critical Medical delivered strong Q2 2026 results with revenue rising 60.7% YoY to $72.5 million, propelled by clinical segment growth and three strategic acquisitions. Adjusted EBITDA reached $7.9 million, and the company raised full-year guidance to $285-$295 million in revenue and $33-$35 million in adjusted EBITDA. Logistics margins faced temporary pressure but are expected to recover by 2027.
3mo ago
22Jul
Strata Critical Medical to announce Q2FY26 results on August 4
Strata Critical Medical will release Q2FY26 results on August 4, 2026, followed by a conference call at 8:00 am ET hosted by Co-CEOs Melissa Tomkiel and Will Heyburn. The company provides logistics and medical services to the U.S. healthcare industry.
3mo ago
24Jun
Strata buys HLT-NRP for $21.5M to expand transplant platform
Strata Critical Medical, Inc. acquired Heart and Lung Transplant National Recovery Program (HLT-NRP) for $21.5 million, comprising 80% cash and 20% stock. The acquisition expands Strata's transplant clinical business line, with HLT-NRP projected to generate $10.0 million in revenue and $3.1 million in Adjusted EBITDA for the full year 2026.
